VigilantDX

Vigilant Diagnostics LLC has developed patented technology that lets providers make treatment decisions while the patient is still in the office

[VigilantDX @VigilantDx]

See our new home page! https://t.co/nSlK6384WZ

[VigilantDX @VigilantDx]

NEWS! Vigilant Announces More Funding! … #medtech #diagnostics #pointofcare #startups #fundraising @MedicalAlley #UniversityofMinnesotaTechnologyCommercialization https://t.co/2CuH0WdMQF

[VigilantDX @VigilantDx]

We were honored that our founder was invited to speak at this major conference recently. Here's his story... (email us at info(at)https://t.co/20qPwXBomQ if you'd like more information)
https://t.co/yrlq61ivmt…

[VigilantDX @VigilantDx]

We’re happy to announce that Mark Stockhowe has joined Vigilant Diagnostics as CEO. He brings many years of executive experience in technology and healthcare. Read more about him at his LinkedIn profile. Welcome, Mark!

[VigilantDX @VigilantDx]

We are pleased to welcome long-time advisor Dan Chen to our board of governors. Dan is President of 3M’s Transportation Safety Division and has 30 years experience in R&D, marketing, strategy, and M&A. He is co-inventor on eleven filed or issued patents. https://t.co/OQMiywEox1

[VigilantDX @VigilantDx]

A new VigilantDX "Team" page is now live on our website! https://t.co/OQMiywEox1 ...
To connect with our new CEO, see https://t.co/POqi9VKsBt.

[VigilantDX @VigilantDx]

did you know we have three issued #patents for our #diagnostictechnology? check them out here: https://t.co/4pp75PnoeS (scroll to bottom)

[VigilantDX @VigilantDx]

see this just-published paper showing our technology achieves sensitivity overlapping with #PCR (laboratory) testing for detection of the spike protein for SARS-CoV-2 (#COVID): https://t.co/EB9Qi5w8Af

[VigilantDX @VigilantDx]

our latest published paper shows Thermal Contrast Amplification (TCA) reading improved overall #influenza sensitivity by 53% for influenza A and 33% for influenza B over visual RIDTs readings... https://t.co/CbtwdMTQws

[VigilantDX @VigilantDx]

check out this new paper: "Ultrasensitive and Highly Specific Lateral Flow Assays for Point-of-Care Diagnosis" (our founder and CTO are two of the authors) https://t.co/weyfp0fvX0

[VigilantDX @VigilantDx]

an education in #CovidTesting... scroll down to this link: “You can read Dr. Mina’s full reply here” — which also includes Elon’s reaction to it https://t.co/aU9PZL8MDZ

[VigilantDX @VigilantDx]

thank you, #RamaOnHealthcare for featuring us on your site and in your newsletter! https://t.co/knwfSLnV8S

[VigilantDX @VigilantDx]

To learn more about Vigilant's market, the problem we address, our solution, our experienced management team, and more, please download our Executive Summary here: https://t.co/fiLy5PYJk8

[VigilantDX @VigilantDx]

in this paper, we show that a simple, commonly used diagnostic technology can compete with more expensive state-of-the-art lab tests…
“The Role of Nanoparticle Design in Determining Analytical Performance of Lateral Flow Immunoassays” https://t.co/VXJ0afS459 #diagnostictesting

[VigilantDX @VigilantDx]

thanks for the opportunity! you can grab our Exec Summary PDF directly at our website via a simple form...

[MedCity News @medcitynews]

Today at Invest Digital Health Virtual Day 4: Home Health track for our startup pitch contest https://t.co/vfMLXPrD5U @f2fhealth @VigilantDx @ElanzaWellness @AireHealth @bluerunventures @uphventures @nexcubed #mcINVEST #digitalhealth

[VigilantDX @VigilantDx]

our pitch at "MedCity INVEST Digital Health" begins about 2:10 pm Central... we look forward to engaging in some great conversations! #mcinvest #diagnostics #homehealth #infectiousdiseases

[VigilantDX @VigilantDx]

please join us at the MedCity INVEST Digital Health Conference, starting today: https://t.co/HNJZEbH4My ... we're excited to present on Thursday! #minnesota #startups #healthcare #diagnostics #infectiousdiseases

[VigilantDX @VigilantDx]

data illustrates the ability of coronavirus tests to detect smaller and smaller amounts of #Covid19 virus... via@FierceBiotech
FDA ranks the performance of 58 molecular coronavirus tests from major developers | FierceBiotech
https://t.co/WKa3GWcvOg

[MedCity News @medcitynews]

5 Home Health startups to watch at INVEST Digital Health virtual Sept 21-25 @medcitynews https://t.co/jvvDIMdx3n @AireHealth @ElanzaWellness @f2fhealth @Omcare_Health @VigilantDx #digitalhealth #mcINVEST

[VigilantDX @VigilantDx]

lots of good things happening at the #UniversityofMinnesota! U's microbiology research facility key to national 'moonshot' effort to fight COVID-19 - https://t.co/xQG4yGbEFU
https://t.co/FqWB0BuvUH